Menu

• Ask a Health Expert about FEBRILE BONE MARROW APLASIA
• Post Your Side Effect related to FEBRILE BONE MARROW APLASIA
• FEBRILE BONE MARROW APLASIA and FDA Warnings
• FEBRILE BONE MARROW APLASIA in Patients Wiki
• Report FEBRILE BONE MARROW APLASIA in Drug Side Effect Survey

FEBRILE BONE MARROW APLASIA side effect

What is FEBRILE BONE MARROW APLASIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Rituximab Side Effects Report #5655961-X
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on Feb 25, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . RITUXIMAB dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5660821-4
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Feb 05, 2008. Female patient, weighting 149.9 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . BEVACIZUMAB dosage: 1020 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, INIPOMP, STILNOX, LEXOMIL, DOMPERIDONE, COLPOTROPHINE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5677820-9
Consumer or non-health professional from UNITED KINGDOM reported RITUXIMAB problem on Mar 11, 2008. Male patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . RITUXIMAB dosage: 450 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE. Patient was hospitalized. Patient recovered.

Campath Side Effects Report #5639630-8
CAMPATH problem was reported by a Health Professional from FRANCE on Feb 12, 2008. Male patient, 19 years of age, was diagnosed with lymphoproliferative disorder and was treated with CAMPATH. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, pancytopenia, . CAMPATH dosage: TOTAL DAILY DOSE: 3 MG. Patient was hospitalized. Patient recovered.


Rituximab Side Effects Report #5548338-9
Physician from UNITED KINGDOM reported RITUXIMAB problem on Dec 03, 2007. Female patient, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5548343-2
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on Dec 03, 2007. Female patient was diagnosed with chronic lymphocytic leukaemia and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 860 MG, UNK. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE, PANADO. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5558013-2
Physician from FRANCE reported TEMODAL problem on Dec 04, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, haematotoxicity, hypokalaemia, . TEMODAL dosage: 150 MG/M2;QD;PO; 340 MG;QD;PO. During the same period patient was treated with LEVOTHYROX, PANTOPRAZOLEE, RYTHMOL, INDAPAMIDE, TANAKAN, ZOPICLONE, DIAMICRON. Patient was hospitalized. Patient recovered.

Advil Side Effects Report #5518033-0
ADVIL problem was reported by a Health Professional from FRANCE on Nov 07, 2007. Male patient was diagnosed with teething, pyrexia and was treated with ADVIL. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, granulocytes maturation arrest, . ADVIL dosage: unknown. During the same period patient was treated with ZYMAFLUOR, TAZOCILLINE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5520143-9
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Nov 05, 2007. Male patient, 62 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . ENDOXAN dosage: unknown. During the same period patient was treated with METHOTREXATE, DOXORUBICIN, MABTHERA, VINCRISTINE, CORTANCYL. Patient was hospitalized. Patient recovered.


Cisplatin Side Effects Report #5479582-7
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2007. Male patient, 57 years of age, weighting 90.39 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . CISPLATIN dosage: unknown. During the same period patient was treated with NEULASTA, FLUOROURACIL, EPIRUBICIN. Patient was hospitalized. Patient died on 03/23/2007.

Cisplatin Side Effects Report #5485368-X
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Oct 03, 2007. Male patient, 57 years of age, weighting 90.39 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, malignant neoplasm progression, neutropenia, thrombocytopenia, . CISPLATIN dosage: unknown. During the same period patient was treated with NEULASTA, FLUOROURACIL, EPIRUBICIN. Patient was hospitalized. Patient died on 03/23/2007.

Bevacizumab Side Effects Report #5452655-0
BEVACIZUMAB problem was reported by a Physician from UNITED KINGDOM on Aug 30, 2007. Female patient was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . BEVACIZUMAB dosage: 1020 MG, Q3W. During the same period patient was treated with CISPLATIN, GEMCITABINE, INIPOMP, STILNOX, LEXOMIL, COLPOTROPHINE. Patient was hospitalized. Patient recovered.

Bicnu Side Effects Report #5405253-9
Health Professional from FRANCE reported BICNU problem on Aug 02, 2007. Female patient, 15 years of age, was diagnosed with hodgkin's disease stage iii and was treated with BICNU. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, mucosal inflammation, . BICNU dosage: unknown. During the same period patient was treated with VINDESINE, ADRIAMYCIN PFS, ETOPOSIDE, METHYLPREDNISOLONE, ZOFRAN, LARGACTIL, BACTRIM. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5415725-9
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 06, 2007. Female patient, 59 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, hyperthermia, . ENDOXAN dosage: unknown. During the same period patient was treated with VINCRISTINE SULPHATE, DOXORUBICIN HYDROCHLORIDE, CORTANCYL, RITUXAN. Patient was hospitalized. Patient recovered.


Neulasta Side Effects Report #5398984-0
Physician from FRANCE reported NEULASTA problem on July 16, 2007. Male patient, weighting 90.39 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . NEULASTA dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient died on 03/23/2007.

Neulasta Side Effects Report #5398984-0
NEULASTA problem was reported by a Physician from FRANCE on July 16, 2007. Male patient, weighting 90.39 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . NEULASTA dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient died on 03/23/2007.

Endoxan Side Effects Report #5763696-8
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on May 29, 2008. Male patient, 53 years of age, was diagnosed with burkitt's lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . ENDOXAN dosage: unknown. During the same period patient was treated with ONCOVIN, METHOTREXATE, ADRIAMYCIN PFS, PREDNISOLONE. Patient recovered.

Cyclophosphamide Side Effects Report #5764829-X
CYCLOPHOSPHAMIDE problem was reported by a Consumer or non-health professional from UNITED STATES on May 29, 2008. Male patient, 23 years of age, was diagnosed with burkitt's lymphoma and was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, peroneal muscular atrophy, . CYCLOPHOSPHAMIDE dosage: unknown. During the same period patient was treated with ONCOVIN, METHOTREXATE, ADRIAMYCIN PFS, PREDNISOLONE. Patient recovered.

Capecitabine Side Effects Report #5766511-1
Physician from FRANCE reported CAPECITABINE problem on May 29, 2008. Male patient, weighting 154.3 lb, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, metabolic acidosis, necrotising colitis, oesophagitis, . CAPECITABINE dosage: UNITS REPORTED: MG. TEMPORARILY INTERRUPTED.. Patient was hospitalized. Patient recovered.


Venofer Side Effects Report #5767117-0
VENOFER problem was reported by a Health Professional from SWITZERLAND on May 26, 2008. Female patient, 55 years of age, was treated with VENOFER. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, infection, . VENOFER dosage: 100 MG INTRAVENOUS. During the same period patient was treated with POTASSIUM CHLORIDE, PRAZEPAM, FOLIC ACID, CLONAZEPAM, VINORELBINE, PEGFILGRASTIM. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5773114-1
Physician from UNITED KINGDOM reported RITUXIMAB problem on June 03, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 600 MG, UNK. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Rituximab Side Effects Report #5786604-2
RITUXIMAB problem was reported by a Physician from UNITED KINGDOM on June 11, 2008. Female patient was diagnosed with mantle cell lymphoma and was treated with RITUXIMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . RITUXIMAB dosage: 600 MG, UNK. During the same period patient was treated with DOXORUBICIN, VINCRISTINE, CYCLOPHOSPHAMIDE, PREDNISOLONE. Patient was hospitalized. Patient recovered.

Emend Side Effects Report #5789309-7
Health Professional from FRANCE reported EMEND problem on June 20, 2008. Female patient, 67 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer metastatic and was treated with EMEND. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, pyrexia, . EMEND dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748771-6
VELCADE problem was reported by a Physician from FRANCE on May 14, 2008. Male patient, 57 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CISPLATIN, ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748797-2
Physician from FRANCE reported VELCADE problem on May 14, 2008. Female patient, 47 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pseudomonas infection, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5748798-4
VELCADE problem was reported by a Physician from FRANCE on May 12, 2008. Female patient, 62 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . VELCADE dosage: 2.00 MG. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Xeloda Side Effects Report #5749871-7
Physician from FRANCE reported XELODA problem on May 15, 2008. Male patient, weighting 154.3 lb, was treated with XELODA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . XELODA dosage: UNITS REPORTED: MG. TEMPORARILY INTERRUPTED.. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5754280-0
VELCADE problem was reported by a Physician from FRANCE on May 15, 2008. Male patient, 51 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN, ALKERAN. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5709656-4
Physician from FRANCE reported TOPOTECAN problem on Apr 07, 2008. Male patient, child 10 years of age, was diagnosed with neuroblastoma and was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . TOPOTECAN dosage: unknown. During the same period patient was treated with VINCRISTINE, DOXORUBICIN. Patient was hospitalized. Patient recovered.

Dactinomycin Side Effects Report #5348486-2
DACTINOMYCIN problem was reported by a Health Professional from FRANCE on May 31, 2007. Male patient was diagnosed with rhabdomyosarcoma and was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, stomatitis, . DACTINOMYCIN dosage: 1.5 MG/M**2; ; IV. During the same period patient was treated with VINCRISTINE SULPHATE, VINCRISTINE SULPHATE, DOXORUBICIN, IFOSFAMIDE. Patient was hospitalized. Patient recovered.

Neulasta Side Effects Report #5358708-X
Physician from FRANCE reported NEULASTA problem on June 04, 2007. Male patient, weighting 90.39 lb, was treated with NEULASTA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, neutropenia, pre-existing disease, thrombocytopenia, . NEULASTA dosage: unknown. During the same period patient was treated with FLUOROURACIL, EPIRUBICIN, CISPLATIN. Patient was hospitalized. Patient died on 03/23/2007.

Caelyx Side Effects Report #5300243-9
CAELYX problem was reported by a Physician from FRANCE on Apr 11, 2007. Female patient, 38 years of age, was diagnosed with ovarian cancer and was treated with CAELYX. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . CAELYX dosage: unknown. During the same period patient was treated with ENDOXAN. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5311755-6
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Apr 17, 2007. Male patient, weighting 105.8 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . BEVACIZUMAB dosage: 900 MG, Q3W. During the same period patient was treated with NAVELBINE, CISPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5269459-4
MABTHERA problem was reported by a Health Professional from GERMANY on Mar 10, 2007. Female patient, 67 years of age, weighting 143.3 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . MABTHERA dosage: 860 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUDARABINE PHOSPHATE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5271872-6
Consumer or non-health professional from FRANCE reported MABTHERA problem on Mar 06, 2007. Female patient, 64 years of age, weighting 132.3 lb, was diagnosed with t-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung disorder, lymphocyte percentage decreased, neutropenia, neutrophil percentage decreased, red blood cell count decreased, white blood cell count decreased, . MABTHERA dosage: 700 MG, UNK; INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5278892-6
VELCADE problem was reported by a Physician from FRANCE on Mar 09, 2007. Female patient, 47 years of age, weighting 165.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung infection, pseudomonas infection, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5278937-3
Physician from FRANCE reported VELCADE problem on Mar 09, 2007. Female patient, 62 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, . VELCADE dosage: unknown. During the same period patient was treated with DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN. Patient was hospitalized. Patient recovered.

Mabthera Side Effects Report #5283162-6
MABTHERA problem was reported by a Health Professional from FRANCE on Mar 20, 2007. Female patient, 64 years of age, weighting 132.3 lb, was diagnosed with t-cell lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung disorder, neutropenia, . MABTHERA dosage: 700 MG UNK, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Temodal Side Effects Report #5676575-1
Physician from FRANCE reported TEMODAL problem on Mar 11, 2008. Female patient, 73 years of age, was diagnosed with glioblastoma and was treated with TEMODAL. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, haematotoxicity, hypokalaemia, mouth haemorrhage, oropharyngeal blistering, purpura, . TEMODAL dosage: 150 MG/M2 QD PO ; 340 MG QD PO ; 255 MG QD PO ; PO. During the same period patient was treated with LEVOTHYROXINE, PANTOPRAZOLE, RYTHMOL, INDAPAMIDE, TANAKAN. Patient was hospitalized. Patient recovered.

Navelbine Side Effects Report #5683442-6
NAVELBINE problem was reported by a Consumer or non-health professional from FRANCE on Mar 14, 2008. Male patient was diagnosed with sarcoma, hiv infection and was treated with NAVELBINE. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, febrile neutropenia, . NAVELBINE dosage: 47 MG QD IV. During the same period patient was treated with ANTIPROTEASE. Patient was hospitalized. Patient recovered.

Depocyt Side Effects Report #5608251-5
Physician from FRANCE reported DEPOCYT problem on Jan 10, 2008. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia, central nervous system leukaemia and was treated with DEPOCYT. After drug was administered, patient experienced the following problems/side effects: cauda equina syndrome, febrile bone marrow aplasia, . DEPOCYT dosage: 50 MG; QOW; INTH. During the same period patient was treated with METHOTREXATE, CYTARABINE, CORTICOSTEROIDS, AZACITIDINE. Patient was hospitalized. Patient recovered.

Lysodren Side Effects Report #5509019-0
LYSODREN problem was reported by a Health Professional from FRANCE on Oct 29, 2007. Female patient, 59 years of age, was diagnosed with adrenocortical carcinoma and was treated with LYSODREN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile bone marrow aplasia, . LYSODREN dosage: unknown. During the same period patient was treated with CISPLATIN, DOXORUBICIN, VEPESID. Patient was hospitalized. Patient recovered.

Zofran Side Effects Report #5512916-3
Consumer or non-health professional from FRANCE reported ZOFRAN problem on Oct 31, 2007. Male patient, 67 years of age, was diagnosed with laryngeal cancer and was treated with ZOFRAN. After drug was administered, patient experienced the following problems/side effects: diarrhoea, febrile bone marrow aplasia, radiation mucositis, . ZOFRAN dosage: 8MG PER DAY. During the same period patient was treated with TAXOTERE, CISPLATIN, FLUOROURACIL, PLITICAN. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5519442-6
ENDOXAN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2007. Male patient, 57 years of age, was diagnosed with lymphoma and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: anorexia, febrile bone marrow aplasia, mucosal inflammation, . ENDOXAN dosage: unknown. During the same period patient was treated with DOXORUBICIN, METHOTREXATE, BLEOMYCIN, MABTHERA, ELDISINE, CORTANCYL. Patient was hospitalized. Patient recovered.

Endoxan Side Effects Report #5474433-9
Consumer or non-health professional from UNITED STATES reported ENDOXAN problem on Sept 21, 2007. Female patient, 67 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with ENDOXAN. After drug was administered, patient experienced the following problems/side effects: febrile bone marrow aplasia, lung disorder, . ENDOXAN dosage: unknown. During the same period patient was treated with FLUDARA. Patient was hospitalized. Patient died on 07/26/2007.

Avastin Side Effects Report #5477376-X
AVASTIN problem was reported by a Physician from UNITED KINGDOM on Sept 19, 2007. Female patient was diagnosed with breast cancer metastatic and was treated with AVASTIN. After drug was administered, patient experienced the following problems/side effects: disseminated intravascular coagulation, febrile bone marrow aplasia, hepatic failure, . AVASTIN dosage: 10 MG/KG, UNK. During the same period patient was treated with TAXOL. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5479841-8
Health Professional from GERMANY reported CETUXIMAB problem on Sept 24, 2007. Female patient, 46 years of age, was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile bone marrow aplasia, pain, renal failure, thrombocytopenia, . CETUXIMAB dosage: ,250 MG/M2 MOST RECENT INFUSION 23JUL2007. During the same period patient was treated with CISPLATIN, TOPOTECAN. Patient was hospitalized. Patient recovered.

Cetuximab Side Effects Report #5481665-2
CETUXIMAB problem was reported by a Health Professional from GERMANY on Sept 21, 2007. Female patient, 70 years of age, was diagnosed with squamous cell carcinoma of the cervix and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: anaemia, febrile bone marrow aplasia, thrombocytopenia, . CETUXIMAB dosage: 400 MG/M2 WAS ADMINISTERED ONCE FROM 28-JUN-2007. During the same period patient was treated with CISPLATIN, HYCAMTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5483861-7
Physician from FRANCE reported VELCADE problem on Sept 25, 2007. Male patient, 51 years of age, weighting 160.9 lb, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: c-reactive protein increased, febrile bone marrow aplasia, . VELCADE dosage: unknown. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE, CYCLOPHOSPHAMIDE, ETOPOSIDE, CISPLATIN, ALKERAN. Patient was hospitalized. Patient recovered.

Sutent Side Effects Report #5460643-3
SUTENT problem was reported by a Physician from FRANCE on Sept 07, 2007. Male patient, 57 years of age, was diagnosed with metastatic renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: asthenia, febrile bone marrow aplasia, neutropenia, thrombocytopenia, . SUTENT dosage: unknown. Patient recovered.

Bevacizumab Side Effects Report #5377473-3
Consumer or non-health professional from UNITED KINGDOM reported BEVACIZUMAB problem on June 20, 2007. Male patient, weighting 143.3 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: fatigue, febrile bone marrow aplasia, jaundice, pyrexia, . BEVACIZUMAB dosage: 990 MG, Q3W. During the same period patient was treated with CISPLATIN, VINORELBINE, FENTANYL, FORLAX, ACTISKENAN, NEXIUM, LEXOMIL. Patient was hospitalized. Patient recovered.